Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips EVgo (NASDAQ: EVGO ) stock is in the news Friday following news that the electric vehicle (EV) charging company signed a deal with Chase. Source: Sundry Photography / Shutterstock.com The banking division of ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Trevi Therapeutics (NASDAQ: TRVI ) stock is slipping on Friday but that’s only after the biopharmaceutical company saw a massive rally yesterday. Source: Ruslan Ivantsov / Shutterstock.com So what was b...
Gainers: Momentus (MNTS) +49%. Trevi Therapeutics (TRVI) +49%. Sunshine Biopharma (SBFM) +34%. Werewolf Therapeutics (HOWL) +30%. System1 (SST) +27%. AppTech Payments (APCX) +22%. MiNK Therapeutics (INKT) +21%. Ikena Oncology (IKNA) +19%. Sprinklr (CXM) +18%. PhaseBio Pharmaceuticals (PHAS) +...
Gainers: Trevi Therapeutics (TRVI) +36%. Sunshine Biopharma (SBFM) +31%. IMAC Holdings (IMAC) +28%. Werewolf Therapeutics (HOWL) +25%. Ikena Oncology (IKNA) +22%. Losers: Aptinyx (APTX) -47%. Vapotherm (VAPO) -29%. Rite Aid (RAD) -23%. Biophytis (BPTS) -13%. Science 37 Holdings (SNC...
Should you buy dogecoin or penny stocks right now? The discussion has come up in recent weeks as the dog-themed cryptocurrency took a tumble down to lows of $0.11. This is the lowest price that dogecoin has traded at since 2021. While the stock market is down this week, however, some cheap ...
Trevi Therapeutics (NASDAQ:TRVI) shares dropped 11.05% Thursday morning after the biopharmaceutical company announced a $55M private placement priced at-the-market under Nasdaq rules. The firm entered into a definitive agreement with certain healthcare-focused institutional investor...
Trevi Therapeutics Announces $55 Million Private Placement Priced At-the-Market PR Newswire Proceeds To Fund the Development of Haduvio for Chronic Cough in Idiopathic Pulmonary Fibrosis NEW HAVEN, Conn. , April 7, 2022 /PRNewswire/ -- Trevi Thera...
Trevi Therapeutics to Participate at 21st Annual Needham Virtual Healthcare Conference PR Newswire Fireside chat will be held on Tuesday, April 12, 2022 , from 8:00 a.m. to 8:40 a.m. EDT NEW HAVEN, Conn. , April 5, 2022 /PRNewswire/ -- T...
Gainers: RCM Technologies (RCMT) +17%. AppHarvest (APPH) +7%. Allogene Therapeutics (ALLO) +7%. Trevi Therapeutics (TRVI) +7%. Latch (LTCH) +5%. Losers: SVB Financial Group (SIVB) -17%. Expensify, Inc. (EXFY) -16%. Masimo Corporation (MASI) -10%. Fiesta Rest...
Trevi Therapeutics Hosting Key Opinion Leader Webinar on the Seriousness of Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF) PR Newswire Webinar will be held on Wednesday, March 30, 2022 , from 8:00 a.m. to 9:00 a.m. EDT NEW HAVEN, Conn. , ...
News, Short Squeeze, Breakout and More Instantly...
Trevi Therapeutics Inc. Company Name:
TRVI Stock Symbol:
NYSE Market:
Trevi Therapeutics Inc. Website:
Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events PR Newswire Two abstracts accepted for oral presentation at the 13 th London International Cough Symposium NEW HAVEN, Conn. , July 2, 2024 /PRNewswire/ -- Trevi Therapeutic...
Trevi Therapeutics to Participate in Upcoming Conferences PR Newswire NEW HAVEN, Conn. , May 9, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™...
Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates PR Newswire Reaffirms guidance for the Phase 2a RIVER trial in refractory chronic cough and Human Abuse Potential (HAP) Study with topline data for each expected in the second half of...